The Discounted Cash Flow (DCF) valuation of Agios Pharmaceuticals Inc (AGIO) is 124.76 USD. With the latest stock price at 29.18 USD, the upside of Agios Pharmaceuticals Inc based on DCF is 327.5%.
Based on the latest price of 29.18 USD and our DCF valuation, Agios Pharmaceuticals Inc (AGIO) is a buy. buying Agios stocks now will result in a potential gain of 327.5%.
| Range | Selected | |
| WACC / Discount Rate | 7.1% - 9.5% | 8.3% |
| Long-term Growth Rate | 0.0% - 1.0% | 0.5% |
| Fair Price | 104.61 - 155.95 | 124.76 |
| Upside | 258.5% - 434.5% | 327.5% |